Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.55 |
| ▸ | PPARD | Q03181 | 5/20 | 0.55 |
| ▸ | PPARA | Q07869 | 5/20 | 0.55 |
| ▸ | TOP1 | P11387 | 3/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | F7 | P08709 | 3/20 | 0.55 |
| ▸ | F3 | P13726 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | RXRA | P19793 | 1/20 | 0.55 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | FABP4 | P15090 | 3/20 | 0.53 |
| ▸ | BLM | P54132 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | USP2 | O75604 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26317135 | 1.00 | PPARG (0.55) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL16357053 | 1.00 | PPARG (0.55) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2207906 | 0.94 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2207902 | 0.94 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL11645936 | 0.92 | PPARG (0.63) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL11645940 | 0.92 | PPARG (0.63) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL25542656 | 0.87 | ALDH1A1 (0.67) | PPARGPPARDPPARACYP19A1KMT2A | |
| SCHEMBL25542651 | 0.87 | ALDH1A1 (0.67) | PPARGPPARDPPARACYP19A1KMT2A | |
| SCHEMBL6786331 | 0.87 | PPARG (0.52) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL6786335 | 0.87 | PPARG (0.52) | PPARGPPARDPPARATOP1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11738031-B2 | Compositions and methods for preventing or treating muscle conditions | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
| US-11738031-B2 | Compositions and methods for preventing or treating muscle conditions | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
| US-20220265677-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-08-25 | — | — | US | disclosed |
| US-20190167695-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-06-06 | — | — | US | disclosed |
| CN-101774939-A | Trans-N-(4- hydroxyl-3-methoxybenzy)-8-methyl-5-nonenamide and preparation method thereof | UNIV ZHEJIANG | 2010-07-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190167695-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | PYGM, TNNC1, MYOF | PPARG 127/4885PPARD 379/4885PPARA 148/4885 |
| US-11738031-B2 | Compositions and methods for preventing or treating muscle conditions | PYGM, TNNC1, MYOF | PPARG 127/4885PPARD 379/4885PPARA 148/4885 |
| US-20220265677-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | PYGM, TNNC1, MYOF | PPARG 127/4885PPARD 379/4885PPARA 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.